Fact. you ask any Hematologist or Oncologist they will state emphatically that IBRUTINIB is far better than Idelalisib. IBRUTINIB works miracles on people Refractory to any other drug for the 65 and over age group. IBRUTINIB is the hotty in my eyes. NOT one freeking bit of negative news on IBRUTINIB. Its your call. Period.
INFI drug is effective. Now major investors will be doubling down on the people who can't stomach a drop. I am staying. All Biotech is down. Stay tuned. Gilead will pounce on this opportunity.
I just see it realistically. This is one freeking awesome drug and hematologist and oncologist can't wait until it gets approved. Patients can't wait until the next clinical trial. This will be far better than gleevec. Pharmacyclics nees to hand over the the reigns to JNJ we want to keep this drug a going concern for all those people who will have to depend on it. I can only hope Duggan has brains enough to not think he is a Pharma God. Put the drug in company hands who can put it to best use.
Ibrutinib is far superior than other Lymphoma and Leukemia drugs and ITS NOT TOXIC ASCO will once again PROVE this over and over again. Just wish FDA would approve it NOW.
Hold when ASCO takes place 31 May thru 4 June in Chicago. Can't wait to see the power unleashed. I have yet to see ONE NEGATIVE piece of news on this position. right now it is in a holding pattern. Only fools will sell
Should see a little blip up go to Leukemia and Lymphoma Society website. It's live. Awesome news coming soon. GLTA. Hang tight. There has never been one bit of negative news on the position so hold tight til after ASCO on June, 4 .
Institutions are gobbling up shares for the news and announcements to come soon. If you are not in this Winthorpe can only advise that you assume a position. Clarence Beaks is so wrong on this company. GLTA
This position is way over bought. PFE, MRK, ABT are now less than VRTX is worth. Any rational person would sell but the greedy will get burned. Stay tune. There wont be enough buy orders when everyone is selling. hahahhahahaahaa
Seems they always overstate or mistate the results and the stock drops. GLTA. Sell before VRTX modifies or clarifies there announcement again.
Good Grief its a wonder one little announcement projects so much strength. Gain should of only been 1/4 of what actually occurred. It's not even freeking approved yet.
9 solid pipeline drugs. A large pharma would be foolish not to consider purchasing this company.
GSK own 30% plus of this company now. Really if they just purchase remaining assets it would just be a balance sheet transaction for GSK while at the same time increase its cash position.
Please break 70. No logical reason she is declining. And yes THRX is a gem now. 45 is buy out price for GSK.